Status: Finalised First registered on: 20/12/2017
Last updated on: 19/09/2019
1. Study identification
EU PAS Register NumberEUPAS22075
Official titleEU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care (20150333)
Study title acronym
Study typeObservational study
Brief description of the study
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre nameAmgen
Centre locationUSA
Details of (Primary) lead investigator
Title Dr
Last name Amgen Inc.
First name Global Development Leader
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Multiple centres

In total how many centres are involved in this Study?153
Countries in which this study is being conducted
International study

Austria
Belgium
Czech Republic
Denmark
France
Germany
Greece
Hungary
Ireland
Italy
Netherlands
Poland
Romania
Slovakia
Spain
Sweden
Ukraine
United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed17/11/201617/11/2016
Start date of data collection01/06/201701/06/2017
Start date of data analysis22/02/201922/02/2019
Date of interim report, if expected
Date of final study report19/09/201916/08/2019
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesAmgen Ltd.100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Amgen Inc.
First name Global Development Leader
Address line 1One Amgen Center Drive
Address line 2 
Address line 3 
CityThousand Oaks 
Postcode91320-1799 
CountryUnited States
Phone number (incl. country code)18054473505 
Alternative phone number 
Fax number (incl. country code) 
Email address medinfo@amgen.com
Public Enquiries
Title Ms 
Last name Amgen Inc. 
First name Global Development Leader 
Address line 1One Amgen Center Drive 
Address line 2 
Address line 3 
CityThousand Oaks 
Postcode91320-1799 
CountryUnited States 
Phone number (incl. country code)18054473505 
Alternative phone number 
Fax number (incl. country code) 
Email address medinfo@amgen.com 
Top